A patient presented with the unique clinical picture of diffuse cutaneous and mucosal leishmaniasis caused by Leishmania tropica. Elevated serum levels of several cytokines including interleukin (IL) 2, interferon g (IFN-g), and tumor necrosis factor a were found. All cytokine levels returned to normal during therapy. No IL-10 or IL-4 levels were detectable. In whole blood cultures, induction of IFN-g by lipopolysaccharide (LPS) was completely negative, even after therapy. Concanavalin A (Con A) -induced release of IFN-g, like Con A -induced release of the other cytokines, was only initially impaired but returned to normal during therapy. Induction of the other cytokines by LPS was never impaired. The low expression of human leukocyte antigen DR on monocytes increased during IFN-g therapy but dropped when IFN-g treatment was ceased. We conclude that in this patient one or more of the routes of IFN-g production was impaired, thus resulting in insufficient IFN-g production in the infected lesions (although IFN-g was systemically present). . In addition, in bone marrow samples from patients with visceral leishmaniasis, elehelper lymphocytes. Insufficient activation by IFN-g of monocytes and, thereby, lack of intracellular killing are thought to vated mRNA levels of both IL-10 and IFN-g, but not IL-4, were found [12]. be the reason for a non-self-limiting course of the infection [5] . The immune reactions leading to either sufficient monocyte
Leishmania tropica is generally assumed to cause cutaneous of IFN-g producing Th1 cells and are powerful inhibitors of monocyte activation by IFN-g [7, 8] . leishmaniasis with a single or only a few localized cutaneous lesions. Recent reports have extended the clinical picture of Under certain conditions, however, leishmanial infection may also result in suppression of Th1 function without concom-L. tropica infection to localized mucosal lesions and to visceral disease [1 -3] . Other Old World Leishmania species are often itant increase of Th2 activity [9] . Further, the dichotomy of Th1 and Th2 responses in leishmanial infection in humans has associated with visceral disease (Leishmania donovani) or with cutaneous lesions (Leishmania major).
not been demonstrated by all investigators. One group found elevated levels of IL-4 in serum samples from patients with Leishmania species are intracellular parasites of monocytes, macrophages, and Langerhans cells [4] . Effective killing of visceral leishmaniasis [10] , while other researchers measured markedly increased IFN-g levels in serum samples from such intracellular parasites requires IFN-g, which is usually contributed by natural killer cells and the Th1 subpopulation of T patients but failed to detect IL-4 [11] . In addition, in bone marrow samples from patients with visceral leishmaniasis, elehelper lymphocytes. Insufficient activation by IFN-g of monocytes and, thereby, lack of intracellular killing are thought to vated mRNA levels of both IL-10 and IFN-g, but not IL-4, were found [12] . be the reason for a non-self-limiting course of the infection [5] . The immune reactions leading to either sufficient monocyte
The patient described in this report presented with a unique clinical picture of diffuse cutaneous and mucosal infection activation with killing of the parasites or insufficient monocyte activation allowing the infection to proceed have been extencaused by L. tropica. We investigated the cytokine profile in serum and measured the cytokine expression in whole-blood sively studied in the murine model. In genetically resistant mice (e.g., C57BL/6), a Th1-type response with predominant cultures in response to the T cell mitogen concanavalin A (Con A) or bacterial lipopolysaccharide (LPS). We further studied production of IL-2 and IFN-g develops, thus resulting in effective killing of the parasites, while in genetically susceptible the expression of human leukocyte antigen DR (HLA-DR) on the patient's monocytes. BALB/c mice, a Th2-type response with production of IL-4 and IL-10 is mounted [6] . Both IL-4 and IL-10 inhibit maturation
Case Report
A 13-year-old boy from Afghanistan who had ''diffuse mu- The palpable lymph nodes decreased in size.
Day 44
All skin ulcera were closed. The growth of the nails started to normalize.
Day 75
The skin's condition dramatically improved, although signs of the previous inflammation were still visible. No Leishmania parasites were detected in biopsy specimens from skin and mucosa, neither microscopically nor by PCR analysis. Day 78
The patient was discharged.
(50 mg/d). Skin lesions were treated with paromomycin in 12% Determination of cytokine levels in serum. Blood was drawn into 10-mL tubes (no. 02.1063; Sarstedt, Nuernbrecht, urea. Parasites were isolated from skin lesions and from lesions of the pharyngeal mucosa. After culturing, the parasites were Germany) and allowed to clot for 30 minutes at 37ЊC. The tubes were then centrifuged, and the serum was withdrawn. characterized by PCR analysis and found to be L. tropica. A short summary of clinical observations during therapy is given All samples were stored at 080ЊC and tested exactly 3 days after they had been collected. To exclude the measurement of in table 1; detailed information on diagnostic and therapeutic procedures will be reported elsewhere (J. Knobloch et al., unexogenous rather than endogenous IFN-g levels by ELISA, the serum samples from the patient were drawn either before published data).
IFN-g therapy was given at all (days 2 and 3) or at least 24 hours after the preceding dose (days 25, 48, and 75).
Materials and Methods
Whole blood cultures. Venous blood was drawn into commercially available tubes containing ammonium heparin (no. At all times indicated, a total of 23 mL of blood was drawn for the in vitro tests described here. Informed consent was 02.1064; Sarstedt). Fifty microliters of anticoagulated blood and 400 mL of culture medium were pipetted into sterile polyobtained from the patient and his guardians. All tests were done in accordance with the standards of the ethical commission styrene tubes with caps (no. 2058; Falcon, Heidelberg, Germany). Fifty microliters of LPS or Con A was added, and of the University of Tuebingen. A healthy 31-year-old male laboratory worker was used as control.
50 mL of the culture medium was added to unelicited cultures. The cultures were incubated for 24 hours (90% humidity and Materials. ELISAs for determination of soluble IL-2 receptor (IL-2R) were from T Cell Diagnostics (Cambridge, 5% CO 2 ).
Immunophenotyping. One hundred microliters of EDTA-MA), ELISA kits for determination of IFN-g were from Endogen (Boston), and ELISA kits for determination of IL-2, IL-4, anticoagulated blood was pipetted into polystyrene tubes (no. 2052; Falcon). The conjugated antibodies were added in satura-IL-6, IL-8, IL-10, IL-12, transforming growth factor b1 (TGFb1), TNF-a, and TNF-b were from R&D Systems (Minneapotion, and the tubes were incubated (20 minutes at room temperature in darkness). After lysing of the RBCs (lysing solution lis). Antibodies used for flow cytometry were conjugated antibody to CD14 tri-color (HHCD1406; Caltag, San Francisco), no. 920017, Becton Dickinson) the leukocytes were washed two times with 2 mL of PBS. Data were acquired within 1 fluorescein isothiocyanate -conjugated antibodies to CD3 and CD45, and phycoerythrin-conjugated antibodies to CD19 and hour with a three-color flow cytometer (Epics XL; Coulter, Hialeah, FL). Isotype controls were always included. HLA-DR (Becton Dickinson, Heidelberg, Germany). The heparin used for the culture medium of the cell stimulation assay was Liquemin N 2500 (lot 11121; Roche, Grenzach-Wyhlen, Results Germany). The culture medium was RPMI 1640 (GIBCO, Eggenstein, Germany) supplemented as described recently with At the start of therapy, the Th1-associated cytokines IL-2, IFN-g (figure 1), and TNF-b (table 2) were present in the 30 U of heparin/mL [13] . The LPS used for stimulation of the whole blood cultures was from Salmonella typhimurium (lot patient's serum. Each of these cytokine levels peaked on day 12, which coincided with a marked increase in T cells of 50% 40H 4000; Sigma, Deisenhofen, Germany); the final concentration in the cell cultures was 1 ng/mL. Con A was obtained (data not shown). After day 12, the cytokine levels declined and finally were no longer detectable. In the cultures from the from Pharmacia (PM 10646; Freiburg, Germany); the final concentration in the cell cultures was 10 mg/mL. control subject, Con A induced sizable amounts of IL-2 and / 9c40$$de02 11-04-97 17:42:07 cidal UC: CID IFN-g ( figure 2 ). In the cultures of the patient's cells, Con Aof these cytokines, the release was calculated in relation to the lymphocyte numbers present in the whole blood cultures. induced release of IL-2 was low on day 12 but then increased. Con A -induced release of IFN-g was negative on day 3 but None of the Th2-associated cytokines, IL-4 and IL-10, were detected in the serum samples from the patient or the control. increased thereafter.
LPS did induce sizable amounts of IFN-g in control cultures, No IL-4 was found in the supernatants of unelicited, LPSstimulated, or Con A -stimulated whole blood cultures of cells which is a normal phenomenon in whole blood cultures as applied here. In the patient's cultures, in contrast, the LPSfrom the patient or the control. The LPS-induced release of IL-10 in the patient's cultures was comparable with that in the induced release of IFN-g was completely negative for the whole observation period. It is interesting that we found uneliccontrol cultures (figure 2). Similar to Con A -induced release of TNF-b, Con A -induced release of IL-10 was completely ited release of IFN-g in the patient's cultures on day 3 ( figure  2 ). This unelicited release of IFN-g was not observed in the suppressed until day 75. For technical reasons, we have no data for IL-10 levels in the supernatants on day 3. presence of both LPS and Con A. On day 12, only borderline amounts of unelicited IFN-g were detectable, while the re-TNF-a, IL-2R (figure 1), TNF-b, IL-6, IL-8, and IL-12 (table 2) initially were present in the patient's serum in high amounts. sponse to Con A was almost restored. On all other days, there was no unelicited release of IFN-g.
All cytokine levels declined to normal values during therapy. TGF-b1 levels increased during therapy, finally reaching the TNF-b was not inducible by Con A until day 75 (table 3) . For technical reasons, we have no data for IL-2 levels in the control levels (table 2) . There was no difference between the patient and the control in regard to LPS-induced release of TNFsupernatants on day 3. Since lymphocytes are the major source / 9c40$$de02 11-04-97 17:42:07 cidal UC: CID Soluble IL-2R initially was detected in the patient's serum, with levels that were 20-fold greater than control levels (figure 1). These levels declined during therapy, but on day 75, a level of 753 U/mL (vs. 348 U/mL for the control) was still found.
Another prominent finding was the very low expression of HLA-DR on the patient's monocytes. The mean fluorescence intensity (MFI) of the patient's monocytes stained with antibodies to HLA-DR was 4.7 compared with 32.0 for the control ( figure 3) . The control value was in the range recently found for a group of 23 healthy volunteers, for whom we measured HLA-DR expression on monocytes with a mean MFI { SD of 45 { 16 (C. Weinstock et al., unpublished data). During therapy with IFN-g, the MFI of HLA-DR expression on monocytes increased and finally reached the control expression level. Although abundant IFN-g was administered, the patient's HLA-DR expression on monocytes did not exceed that of the control. When the first course of IFN-g therapy was finished, the expression of HLA-DR dropped to pretherapy values.
Discussion
Leishmania species are intracellular parasites of monocytes and macrophages. Activation of the monocytes' intracellular killing mechanisms is the pivotal step in controlling leishmanial infection [5] . IFN-g plays a key role in the activation of monocytes. It increases the production of oxygen radicals and NO, thereby leading to intracellular killing [14] .
When monocytes are activated by IFN-g, the expression of HLA-DR on their surface increases [15] . In the patient described here, HLA-DR expression on monocytes before therapy was very low, reflecting insufficient activation of his monocytes. Insufficient monocyte activation (with insufficient intracellular killing) could explain why the leishmanial infection in this patient was not self-limiting but developed into a diffuse mucocutaneous infection. The insufficient activation of the patient's monocytes seemed to be in contradiction to the sizable amounts of IFN-g present in his serum. Further, despite the administration of abundant IFN-g, it took 3 weeks to reach an HLA-DR expression on the patient's monocytes that was comparable with the control expression level. When IFN-g We searched for IL-10 and TGF-b, two inhibitors of monocyte activation known to play a role in leishmanial infection [16 -18] . Nothing pointed to a role for either inhibitor in our case. In fact, these two inhibitors were, together with IL-4, the a and IL-6 (table 3), whereas Con A-induced release initially was ú10-fold decreased (TNF-a) or even completely suppressed only cytokines that were not elevated (TGF-b) or not present in the serum (IL-10). In addition, the unimpaired release of the (TNF-b, IL-6, and IL-10) for the patient. During therapy, Con A-induced release of TNF-a, TNF-b, IL-6, and IL-10 recovered.
primarily monocyte-derived cytokines TNF-a and IL-10 by / 9c40$$de02 11-04-97 17:42:07 cidal UC: CID NOTE. Con A Å concanavalin A; LPS Å lipopolysaccharide; ND Å not determined. * Fifty microliters of anticoagulated blood and 400 mL of culture medium were pipetted into tubes; 50 mL of LPS, Con A, or culture medium (unelicited controls) were added. After incubation (24 hours at 90% humidity and 5% CO 2 ), the supernatants were tested by ELISA.
LPS-stimulated whole blood cultures votes against the presence in whole blood cultures of Con A -induced cytokine production was reversed after therapy, it could have been due to either an of an inhibitor of monocytes.
Other findings point to a mechanism working via lymphoinhibitor that was removed by therapy or a lack of a producer population that would have grown out due to therapy. cytes. In vitro production of all lymphokines and monokines tested in response to Con A was markedly suppressed or even A shift toward a Th2-type response has been invoked in abrogated despite the fact that (1) sizable amounts of them leishmaniasis in the mouse model and has been discussed as were found in serum and (2) several of them (IL-2, IL-8, and reason for the insufficient monocyte activation in human cuta-IFN-g) were released in unelicited cultures. Since suppression neous leishmaniasis [6, 19] . However, the cytokine pattern measured in serum and cell cultures does not favor the possibility that a shift in the ratio of Th1-type/Th2-type cells was implicated in this patient. It is therefore quite possible that the suppression of mitogen-induced cytokine production was due to the presence of an inhibitor in the serum. One proven inhibitor of lymphocyte activation was indeed ominously elevated in the serum of our patient: soluble IL-2R. This result is in concordance with the findings of other investigators for patients with leishmaniasis [20]; Barral-Netto et al. also showed that elevated soluble IL-2R levels were responsible for the suppression of Con A -induced production of IL-2 and IFN-g by the serum of patients with visceral leishmaniasis. Elevation of soluble IL-2R levels in our patient's serum therefore offers a straightforward explanation for the impaired induction of IL-2 and IFN-g by Con A. The role of IL-2 as cofactor for IFN-g in the induction of macrophage resistance to Leishmania has been proven [21] . It is therefore quite possible that the high soluble IL-2R levels in our patient 
